Unlocking Precision in Prostate Cancer Care: Part 1

Post: Grateful for the opportunity to collaborate with Urology Times and Hanna Clarke on this insightful interview series! ??

If you're managing prostate cancer patients, incorporating guideline-based genetic testing can revolutionize treatment strategies. In this first segment, I discuss the critical importance of vigilant screening, the impact of genetic testing, and how PARP inhibitors are shaping personalized care.

Stay tuned for more in Part 2!

https://www.urologytimes.com/view/joy-maulik-crnp-on-the-growing-role-of-parp-inhibitors-in-prostate-cancer